These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Intravenous theophylline therapy. Effect of solubilizers on the incidence of adverse local effects in the area of infusion?]. Staib AH; Kyrein HJ Fortschr Med; 1984 Jun; 102(23):643-6. PubMed ID: 6469175 [TBL] [Abstract][Full Text] [Related]
4. Guidelines for avoiding theophylline overdose. Hendeles L; Weinberger M N Engl J Med; 1979 May; 300(21):1217. PubMed ID: 431654 [No Abstract] [Full Text] [Related]
5. [The dose-concentration nomogram for intravenous theophylline therapy]. Awaya M; Ryuge K Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Sep; 20(9):957-66. PubMed ID: 7154445 [No Abstract] [Full Text] [Related]
7. Poisoning patients with intravenous theophylline. Hendeles L; Weinberger M Am J Hosp Pharm; 1980 Jan; 37(1):49-50. PubMed ID: 7361773 [No Abstract] [Full Text] [Related]
8. Intravenous maintenance aminophylline dosage in patients with asthma on regular oral theophylline. Chang KC; Chai H; Miles-Lawrence R; Bell TD; Pinney CT Ann Allergy; 1982 Dec; 49(6):315-7. PubMed ID: 7149347 [TBL] [Abstract][Full Text] [Related]
9. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route]. Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461 [TBL] [Abstract][Full Text] [Related]
11. Prediction of steady state theophylline concentration during drug infusion. Johnson GF Iowa Med; 1984 Aug; 74(8):347-8, 350, 352. PubMed ID: 6490341 [No Abstract] [Full Text] [Related]
12. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results. Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961 [TBL] [Abstract][Full Text] [Related]
13. [Tolerance and effect of short-term theophylline infusions]. Schmidt M Pneumologie; 1993 Jan; 47(1):30-5. PubMed ID: 8437976 [TBL] [Abstract][Full Text] [Related]
14. Guidelines for rapid attainment of therapeutic serum theophylline concentrations. Hendeles L; Weinberger M Am J Hosp Pharm; 1982 Feb; 39(2):249-50. PubMed ID: 7058793 [No Abstract] [Full Text] [Related]
15. I.V. dosage guidelines for theophylline products. FDA Drug Bull; 1980 Feb; 10(1):4-6. PubMed ID: 7358241 [No Abstract] [Full Text] [Related]
16. Evaluation of the ordering of serum theophylline concentrations. Gentry SM; Keith TD; McMillan DM; Goetter WE Am J Hosp Pharm; 1981 Dec; 38(12):1937-9. PubMed ID: 7325177 [TBL] [Abstract][Full Text] [Related]
17. A standard aminophylline intravenous solution with flow rate label adapted to a manufacturer's standard solution. Jurkiewicz GL; Gambino DA; Bloome GA Hosp Pharm; 1983 Dec; 18(12):672, 674-6. PubMed ID: 10264361 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Chiou method for determining theophylline dosages. Johnson MH; Burkle WS Clin Pharm; 1984; 3(2):174-8. PubMed ID: 6723223 [TBL] [Abstract][Full Text] [Related]
19. [Practicability, effectiveness and tolerance of a standardized prepared theophylline infusion]. Pohl WR; Kummer F; Lorber H; Würtz J; Aigner K; Pfeiffer KP Acta Med Austriaca; 1996; 23(3):105-8. PubMed ID: 8967286 [TBL] [Abstract][Full Text] [Related]